XML 85 R58.htm IDEA: XBRL DOCUMENT v3.25.4
Acquisitions and Divestitures - Narrative (Details)
 1 Months Ended 3 Months Ended 12 Months Ended
Apr. 10, 2024
USD ($)
shares
Jan. 18, 2024
USD ($)
employee
Oct. 03, 2023
USD ($)
Apr. 05, 2023
USD ($)
shares
Oct. 31, 2023
USD ($)
Jun. 30, 2024
shares
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
materialRight
shares
Dec. 31, 2023
USD ($)
Business Combination [Line Items]                  
Asset Acquisition, Number Of Additional Acquisitions during Period | materialRight               3  
Research and development             $ 243,773,000 $ 424,061,000 $ 580,621,000
Loss on deconsolidation of subsidiaries             0 7,013,000 42,502,000
Accrued expenses and other current liabilities             66,458,000 65,387,000  
General and administrative             183,290,000 246,161,000 385,025,000
Loss on sale of business               7,000,000.0  
Reclassification of foreign currency translation adjustment realized upon sale of foreign subsidiary             $ 0 (1,492,000) $ 0
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Altar                  
Business Combination [Line Items]                  
Loss on sale of business               7,000,000.0  
Reclassification of foreign currency translation adjustment realized upon sale of foreign subsidiary               1,500,000  
Related Party                  
Business Combination [Line Items]                  
Employee lease expense               4,900,000  
Accrued expenses and other current liabilities               1,700,000  
Other Acquisitions                  
Business Combination [Line Items]                  
Asset Acquisition, Consideration Transferred               19,800,000  
Research and development               19,800,000  
StrideBio                  
Business Combination [Line Items]                  
Asset Acquisition, Consideration Transferred       $ 7,600,000          
Research and development               800,000  
Asset acquisition, consideration transferred               $ 0  
Zymergen                  
Business Combination [Line Items]                  
Asset acquisition, price of acquisition, expected     $ 6,200,000            
Common Class A | Other Acquisitions                  
Business Combination [Line Items]                  
Issuance of common stock for a business and asset acquisition (in shares) | shares               394,799  
Common Class A | StrideBio                  
Business Combination [Line Items]                  
Issuance of common stock for a business and asset acquisition (in shares) | shares       119,278   102,922      
Asset Acquisition, Consideration Transferred       $ 6,800,000          
Asset acquisition, consideration transferred         $ 21,300,000        
AgBiome, Inc.                  
Business Combination [Line Items]                  
Business Combination, Consideration Transferred $ 18,200,000                
AgBiome, Inc. | Developed Technology Rights                  
Business Combination [Line Items]                  
Intangibles estimated useful life             3 years    
AgBiome, Inc. | Common Class A                  
Business Combination [Line Items]                  
Issuance of common stock for a business and asset acquisition (in shares) | shares 407,240                
Zymergen Bankruptcy                  
Business Combination [Line Items]                  
Loss on deconsolidation of subsidiaries     42,500,000            
Business combination, equity interest in acquiree, fair value     $ 0            
Equity method investments               $ 0  
Zymergen                  
Business Combination [Line Items]                  
Business Combination, Consideration Transferred   $ 6,200,000              
Number of employees acquired | employee   91              
Payments to Acquire Businesses, Gross   $ 5,400,000              
Business acquire consideration   800,000              
Operating lease right-of-use assets   19,900,000              
Business Combination, Recognized Asset Acquired, Property, Plant, and Equipment   6,000,000.0              
Operating lease liabilities   $ 19,900,000              
General and administrative             $ 0